Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...

Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...

Costs of product revenue were $0.4 million for the quarter ended March 31, 2025, compared to $0.5 million for the quarter ended March 31, 2024, partially due to obsolete inventory write offs of ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

These moving average figures, both SMA and EMA, across various time frames, provide a nuanced understanding of the stock's performance and are pivotal in shaping investment strategies.

These moving average figures, both SMA and EMA, across various time frames, provide a nuanced understanding of the stock's performance and are pivotal in shaping investment strategies.

Then they use a variety of thoroughly vetted fundamental value measures and indicators of near-term price appreciation to rank that universe before constructing a 125- to 185-stock portfolio based ...

At times, however, extreme market pressure can force them to cut their dividends, which hurts stock performance. In this month, the strategy also had more exposure to the Yield factor over its peers.